VEGFA and ischemia: We propose that anti-VEGF therapy inhibits the positive feedback loop because it reduces the levels of downstream inflammatory cytokines such as MCP-1 and IL-8, as well as VEGF itself [122], leading to an improvement of ischemia and inflammation.